Evaluation of the i-gel® Plus supraglottic airway device in
elective surgery: a prospective international multicentre study

J 2024

Evaluation of the i-gel® Plus supraglottic airway device in elective surgery: a prospective international multicentre study

WERNER, Jakub, Olga KLEMENTOVA, Jan BRUTHANS, Jaromir MACOUN, Tomasz GASZYNSKI et. al.

Základní údaje

Originální název

Evaluation of the i-gel® Plus supraglottic airway device in elective surgery: a prospective international multicentre study

Autoři

WERNER, Jakub, Olga KLEMENTOVA, Jan BRUTHANS, Jaromir MACOUN, Tomasz GASZYNSKI, Tomas HENLIN, Will DONALDSON, Erik LICHNOVSKY, Shiva ARAVA, Ana M LOPEZ, Raquel BERGE a Pavel MICHALEK

Vydání

ANAESTHESIA, HOBOKEN, WILEY, 2024, 0003-2409

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30223 Anaesthesiology

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 10.700 v roce 2022

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1111/anae.16401

UT WoS

001285421200001

Klíčová slova anglicky

elective surgery; i-gel (R) Plus; oropharyngeal seal pressure; supraglottic airway device

Štítky

14110122

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 20. 8. 2024 10:48, Mgr. Tereza Miškechová

Anotace

V originále

Background The i-gel (R) Plus is a modified version of the i-gel (R) supraglottic airway device. It contains a wider drainage port; a longer tip; ramps inside the breathing channel; and an additional port for oxygen delivery. There has been no prospective evaluation of this device in clinical practice. Methods This international, multicentre, prospective cohort study aimed to evaluate the performance of the i-gel Plus in adult patients undergoing elective procedures under general anaesthesia. The primary outcome was overall insertion success rate, defined as the ability to provide effective airway management through the device from insertion until the end of the surgical procedure. Secondary outcomes included device performance and incidence of postoperative adverse events. Data from the first 1000 patients are reported. Results In total, 1012 patients were enrolled; 12 forms were excluded from the final analysis due to incomplete data leaving 1000 included patients (545 female). Overall insertion success rate was 98.6%, with a first-attempt success rate of insertion of 88.2%. A significant difference between females and males was seen for the overall success rate (97.4% vs. 99.6% respectively) but not for first-attempt successful insertion. Mean (SD) oropharyngeal seal pressure was 32 (7) cmH(2)O. The only independent factor that increased the risk of first-attempt failure was low operator experience. Complications included desaturation < 85% in 0.6%; traces of blood on the device in 7.4%; laryngospasm in 0.5%; and gastric contents inside the bowl in 0.2% of patients. Conclusions The i-gel Plus appears to be an effective supraglottic airway device that is associated with a high insertion success rate and a reasonably low incidence of complications.

Citovat

WERNER, Jakub, Olga KLEMENTOVA, Jan BRUTHANS, Jaromir MACOUN, Tomasz GASZYNSKI, Tomas HENLIN, Will DONALDSON, Erik LICHNOVSKY, Shiva ARAVA, Ana M LOPEZ, Raquel BERGE a Pavel MICHALEK. Evaluation of the i-gel® Plus supraglottic airway device in elective surgery: a prospective international multicentre study. ANAESTHESIA. HOBOKEN: WILEY, 2024, 8 s. ISSN 0003-2409. Dostupné z: https://dx.doi.org/10.1111/anae.16401.

@article{2424038,
   author = {Werner, Jakub and Klementova, Olga and Bruthans, Jan and Macoun, Jaromir and Gaszynski, Tomasz and Henlin, Tomas and Donaldson, Will and Lichnovsky, Erik and Arava, Shiva and Lopez, Ana M and Berge, Raquel and Michalek, Pavel},
   article_location = {HOBOKEN},
   doi = {http://dx.doi.org/10.1111/anae.16401},
   keywords = {elective surgery; i-gel (R) Plus; oropharyngeal seal pressure; supraglottic airway device},
   language = {eng},
   issn = {0003-2409},
   journal = {ANAESTHESIA},
   title = {Evaluation of the i-gel® Plus supraglottic airway device in elective surgery: a prospective international multicentre study},
   url = {https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.16401},
   year = {2024}
}

TY  - JOUR
ID  - 2424038
AU  - Werner, Jakub - Klementova, Olga - Bruthans, Jan - Macoun, Jaromir - Gaszynski, Tomasz - Henlin, Tomas - Donaldson, Will - Lichnovsky, Erik - Arava, Shiva - Lopez, Ana M - Berge, Raquel - Michalek, Pavel
PY  - 2024
TI  - Evaluation of the i-gel® Plus supraglottic airway device in elective surgery: a prospective international multicentre study
JF  - ANAESTHESIA
PB  - WILEY
SN  - 00032409
KW  - elective surgery
KW  - i-gel (R) Plus
KW  - oropharyngeal seal pressure
KW  - supraglottic airway device
UR  - https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.16401
N2  - Background The i-gel (R) Plus is a modified version of the i-gel (R) supraglottic airway device. It contains a wider drainage port; a longer tip; ramps inside the breathing channel; and an additional port for oxygen delivery. There has been no prospective evaluation of this device in clinical practice. Methods This international, multicentre, prospective cohort study aimed to evaluate the performance of the i-gel Plus in adult patients undergoing elective procedures under general anaesthesia. The primary outcome was overall insertion success rate, defined as the ability to provide effective airway management through the device from insertion until the end of the surgical procedure. Secondary outcomes included device performance and incidence of postoperative adverse events. Data from the first 1000 patients are reported. Results In total, 1012 patients were enrolled; 12 forms were excluded from the final analysis due to incomplete data leaving 1000 included patients (545 female). Overall insertion success rate was 98.6%, with a first-attempt success rate of insertion of 88.2%. A significant difference between females and males was seen for the overall success rate (97.4% vs. 99.6% respectively) but not for first-attempt successful insertion. Mean (SD) oropharyngeal seal pressure was 32 (7) cmH(2)O. The only independent factor that increased the risk of first-attempt failure was low operator experience. Complications included desaturation < 85% in 0.6%; traces of blood on the device in 7.4%; laryngospasm in 0.5%; and gastric contents inside the bowl in 0.2% of patients. Conclusions The i-gel Plus appears to be an effective supraglottic airway device that is associated with a high insertion success rate and a reasonably low incidence of complications.
ER  -

WERNER, Jakub, Olga KLEMENTOVA, Jan BRUTHANS, Jaromir MACOUN, Tomasz GASZYNSKI, Tomas HENLIN, Will DONALDSON, Erik LICHNOVSKY, Shiva ARAVA, Ana M LOPEZ, Raquel BERGE a Pavel MICHALEK. Evaluation of the i-gel® Plus supraglottic airway device in elective surgery: a prospective international multicentre study. \textit{ANAESTHESIA}. HOBOKEN: WILEY, 2024, 8 s. ISSN~0003-2409. Dostupné z: https://dx.doi.org/10.1111/anae.16401.

Podrobný výpis o publikaci